| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | The Landscape of Ferroptosis-Related Gene Signatures as Molecular Stratification in Triple-Negative Breast Cancer![]() | Buta, Marko | Article | 21M21 |
| 2025 | P346 Diazachrysene derivatives as autophagy inhibitors combating pancreatic ductal adenocarcinoma (PDAC) cells![]() | Selaković, Života | Conference Paper | Mp. category will be shown later |
| 2025 | Novel 1-benzhydryl piperazine scaffoldbased HDAC inhibitor b7 induces synergistic antiproliferative effect with vemurafenib in colorectal cancer cells harboring BRAF mutation![]() | Vuletić, Ana | Conference Paper | Mp. category will be shown later |
| 2025 | Identification of a Novel miR-122-5p/CDC25A Axis and Potential Therapeutic Targets for Chronic Myeloid Leukemia![]() | Ozer Yaman, Serap; Petrović, Nina | Article | 21M21 |
| 2025 | Mononuclear isothiocyanate zinc complex with a pyridine-based thiazolyl-hydrazone ligand: Transformation into a 1D coordination polymer and anticancer activity against pancreatic Cancer cell lines![]() | Araskov, Jovana B | Article | 21aM21a |
| 2025 | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents![]() | Beljkaš, Milan | Article | 22M22 |
| 2025 | P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular Modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Unveiling the 4-aminoquinoline derivatives as potent agents against pancreatic ductal adenocarcinoma (PDAC) cell lines![]() | Živanović, Marija; Selaković, Milica | Article | 21aM21a |
| 2024 | Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design![]() | Beljkaš, Milan | Article | 21aM21a |
| 2024 | Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition![]() | Ćurčić, Vladimir; Olszewski, Mateusz; Maciejewska, Natalia; Višnjevac, Aleksandar; Srdić-Rajić, Tatjana | Article | 21M21 |
| 2024 | Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment![]() | Beljkaš, Milan | Conference Paper | Mp. category will be shown later |
| 2024 | CB PP 20 Novel 4-aminoquinoline derivatives exhibit pro-ferroptotic activity in MIA PaCa-2 and PANC-1 cell lines![]() | Aleksić, Ljubodrag; Selaković, Milica | Conference Paper | Mp. category will be shown later |
| 2024 | Integrative Framework for Developing Innovative SIRT2 Inhibitors![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Arthrospira platensis Protein Hydrolysates as A Promising Alternatives to Serum in Animal-Cell Culture![]() | Sibinčić, Nikolina | Conference Paper | Mp. category will be shown later |
| 2024 | Screening Algal and Cyanobacterial Extracts to Identify Potential Substitutes for Fetal Bovine Serum in Cellular Meat Cultivation![]() | Sibinčić, Nikolina | Article | 21M21 |
| 2023 | Nischarin expression may have differing roles in male and female melanoma patients![]() | Ostojić, Marija | Article | 21M21 |
| 2023 | Synthesis, characterization, and in vivo evaluation of the anticancer activity of a series of 5- and 6-(halomethyl)-2,2′-bipyridine rhenium tricarbonyl complexes![]() | Nasiri Sovari, Sara; Kolly, Isabelle; Schindler, Kevin; Djurić, Ana | Article | 21aM21a |
| 2023 | Discovery of novel HDAC inhibitors for therapy of triple-negative breast cancer – preclinical study![]() | Ružić, Dušan | Conference Paper | Mp. category will be shown later |
| 2023 | Sulforaphane affects morphological changes and cell viability of colon cancer cells: p53 mutation-dependent effect![]() | Đurić, Ana | Conference Paper | Mp. category will be shown later |